Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Metastase

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Metastase in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19902 (13.33)18.7374
1990's2 (13.33)18.2507
2000's5 (33.33)29.6817
2010's5 (33.33)24.3611
2020's1 (6.67)2.80

Authors

AuthorsStudies
Cao, L; Fang, Z; Jia, D; Mi, J; Pan, Z; Peng, P; Shi, Z; Zhang, Y1
Ferracini, M; Sahu, RP; Travers, JB1
Anandi, VL; Ashiq, KA; Lahiri, M; Nitheesh, K1
Bar-Eli, M; Melnikova, VO1
Demopoulos, CA; Frangia, C; Iatrou, C; Tsoupras, AB1
Danker, K; Reutter, W; Semini, G1
Gullickson, G; Hoover, RG; Kornbluth, J; McHowat, J; Sharma, J; Turk, J1
Laurell, T; Lenshof, A1
Bar-Eli, M; Lev, DC; Melnikova, VO; Mourad-Zeidan, AA1
Im, SY; Jung, B; Kang, JH; Kang, YR; Kim, HA; Kim, KJ; Ko, HM; Lee, HK; Park, SJ1
Karpatkin, S; Pearlstein, E; Salk, PL; Yogeeswaran, G2
Bai, S; Chun, SB; Chung, KC; Ha, TY; Im, SY; Kang, HS; Kim, JW; Ko, HM; Lee, HB; Lee, HK; Lee, YB; Oh, SJ1
Brill, A; Varon, D1
Richards, B1

Reviews

3 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Metastase

ArticleYear
Inflammation and melanoma metastasis.
    Pigment cell & melanoma research, 2009, Volume: 22, Issue:3

    Topics: Chemokines; Disease Progression; Humans; Immune System; Inflammation; Interleukins; Keratinocytes; Melanoma; Neoplasm Invasiveness; Neoplasm Metastasis; Platelet Activating Factor; Platelet Activation; Receptor, PAR-1; Stromal Cells

2009
The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants.
    Infectious disorders drug targets, 2009, Volume: 9, Issue:4

    Topics: Animals; Antioxidants; Humans; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Platelet Activating Factor; Receptors, G-Protein-Coupled

2009
Glycosidated phospholipids: uncoupling of signalling pathways at the plasma membrane.
    British journal of pharmacology, 2010, Volume: 160, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Membrane; Cell Movement; Cell Proliferation; Glycosides; Humans; Inositol; Molecular Structure; Neoplasm Metastasis; Neoplasms; Phospholipids; Platelet Activating Factor; Signal Transduction

2010

Other Studies

12 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Metastase

ArticleYear
α-Hederin inhibits the platelet activating factor-induced metastasis of HCC cells through disruption of PAF/PTAFR axis cascaded STAT3/MMP-2 expression.
    Pharmacological research, 2022, Volume: 178

    Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; DNA-Binding Proteins; Humans; Liver Neoplasms; Matrix Metalloproteinase 2; Molecular Docking Simulation; Neoplasm Metastasis; Oleanolic Acid; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Saponins; Signal Transduction; STAT3 Transcription Factor

2022
Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.
    Mediators of inflammation, 2015, Volume: 2015

    Topics: Animals; Antineoplastic Agents; Antioxidants; Etoposide; Female; Immunosuppression Therapy; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Transplantation; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Signal Transduction

2015
Platelet-activating factor promotes motility in breast cancer cells and disrupts non-transformed breast acinar structures.
    Oncology reports, 2016, Volume: 35, Issue:1

    Topics: Breast Neoplasms; Cell Culture Techniques; Cell Line; Cell Movement; Cell Transformation, Neoplastic; Female; Humans; MAP Kinase Kinase 4; Neoplasm Metastasis; Phosphatidylinositol 3-Kinases; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Signal Transduction

2016
Platelet-activating factor and metastasis: calcium-independent phospholipase A2β deficiency protects against breast cancer metastasis to the lung.
    American journal of physiology. Cell physiology, 2011, Volume: 300, Issue:4

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Group IV Phospholipases A2; Humans; Lung; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Metastasis; Neoplasm Transplantation; Platelet Activating Factor; Tumor Necrosis Factor-alpha

2011
Emerging clinical applications of microchip-based acoustophoresis.
    Journal of laboratory automation, 2011, Volume: 16, Issue:6

    Topics: Acoustics; Biomedical Research; Blood Transfusion; Cell Separation; Flow Cytometry; Humans; Microfluidic Analytical Techniques; Neoplasm Metastasis; Neoplastic Cells, Circulating; Plasmapheresis; Platelet Activating Factor

2011
Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis.
    The Journal of biological chemistry, 2006, Feb-03, Volume: 281, Issue:5

    Topics: Activating Transcription Factor 1; Animals; Cyclic AMP Response Element-Binding Protein; DNA-Binding Proteins; Enzyme Activation; Gene Expression Regulation, Enzymologic; Humans; Matrix Metalloproteinase 2; Melanoma; Mice; Mice, Nude; Neoplasm Metastasis; Nuclear Proteins; Phosphorylation; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Regulatory Factor X Transcription Factors; Signal Transduction; Transcription Factors; Transfection; Tumor Cells, Cultured

2006
Critical role for matrix metalloproteinase-9 in platelet-activating factor-induced experimental tumor metastasis.
    International journal of cancer, 2007, Mar-15, Volume: 120, Issue:6

    Topics: Animals; Lung Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; NF-kappa B; Platelet Activating Factor; Skin Neoplasms; Transcription Factor AP-1

2007
Role of platelets in tumor cell metastases.
    Annals of the New York Academy of Sciences, 1981, Volume: 370

    Topics: Animals; Blood Coagulation Factors; Blood Platelets; Cell Line; Cell Transformation, Neoplastic; Centrifugation; Drug Synergism; Fibroblasts; Hot Temperature; Isoflurophate; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Platelet Activating Factor; Platelet Aggregation; Rats; Rats, Inbred WF; Serotonin; Trypsin

1981
Platelet aggregating material (PAM) of two virally-transformed tumors: SV3T3 mouse fibroblast and PW20 rat renal sarcoma. Role of cell surface sialylation.
    Progress in clinical and biological research, 1982, Volume: 89

    Topics: Animals; Blood Coagulation Factors; Cell Line; Cell Membrane; Cell Transformation, Viral; Cells, Cultured; Humans; Kidney Neoplasms; Mice; Neoplasm Metastasis; Platelet Activating Factor; Platelet Aggregation; Rabbits; Rats; Sarcoma, Experimental; Sialic Acids; Urea

1982
Augmentation of tumor metastasis by platelet-activating factor.
    Cancer research, 1996, Jun-01, Volume: 56, Issue:11

    Topics: Animals; Antineoplastic Agents; Azepines; Female; Interleukin-1; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Platelet Activating Factor; Triazoles; Tumor Necrosis Factor-alpha

1996
Platelets cross-talk with tumor cells.
    Haemostasis, 2001, Volume: 31 Suppl 1

    Topics: Blood Platelets; Cell Adhesion Molecules; Cell Communication; Endothelial Growth Factors; Humans; Lymphokines; Neoplasm Metastasis; Platelet Activating Factor; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Platelet-Derived Growth Factor; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2001
From proteins to protein interacting drugs.
    The Journal of pharmacy and pharmacology, 1992, Volume: 44 Suppl 1

    Topics: Amino Acid Sequence; Antineoplastic Agents; Computer Graphics; Drug Design; Glycoproteins; Humans; Metalloendopeptidases; Metalloproteins; Microbial Collagenase; Molecular Sequence Data; Neoplasm Metastasis; Platelet Activating Factor; Proteins; Tissue Inhibitor of Metalloproteinases

1992